Warm beating heart with deep hypothermic circulatory arrest: A technique for an unclampable aorta with aortic valve regurgitation  by Khalpey, Zain et al.
Surgical Techniquestranscatheter aortic valve implantation. Interact Cardiovasc Thorac Surg.
2012;14:485-7.
3. Unbehaun A, Pasic M, Dreysse S, Buz S, Kukucka M, Hetzer R, Drews T. Trans-
catheter aortic valve implantation and hybrid coronary artery revascularization—
time to combine them. Innovations. 2011;6:395-8.
4. Walther T, Dewey T, Borger MA, Kempfert J, Linke A, Becht R, et al. Transapical
aortic valve implantation: step by step. Ann Thorac Surg. 2009;87:276-83.From the Deutsches Herzzentrum Berlin, Berlin, Germany.
Disclosures: Authors have nothing to disclose with regard to commercial support.
Z.K. and R.J.D. contributed equally to this work.
Received for publication Jan 19, 2012; revisions receivedMarch 9, 2012; accepted for
publication March 19, 2012; available ahead of print April 16, 2012.
Address for reprints: Zain Khalpey, MD, PhD, MRCS, Department of Cardiac Sur-
gery, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St,
Boston, MA 02115 (E-mail: zkhalpey@partners.org).
J Thorac Cardiovasc Surg 2012;144:731-2
0022-5223/$36.00
Copyright  2012 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2012.03.057
The Journal of Thoracic and Ca5. Pasic M, Dreysse S, Drews T, Buz S, Unbehaun A, Kukucka M, et al. Improved
technique of transapical aortic valve implantation: ‘‘the Berlin addition’’ Ann
Thorac Surg. 2010;89:2058-60.
6. Olsen LK, Arendrup H, Engstrom T, Sondergard L. When operable patients be-
come inoperable: conversion of a surgical aortic valve replacement into trans-
catheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2009;9:
837-9.Warm beating heart with deep hypothermic circulatory arrest:
A technique for an unclampable aorta with aortic valve regurgitationZain Khalpey, MD, PhD, MRCS,a,b Rene J. Dekkers, CCP,a,b Foeke J. H. Nauta, MD,a,b and
Prem Shekar, MD,a,b Boston, MassThe presence of severe aortic insufficiency (AI) in pa-
tients with severe atherosclerotic disease of the ascending
aorta at aortic valve replacement (AVR) poses consider-
able technical challenges, often associated with poor out-
comes.1,2 Furthermore, the risk of cerebral embolus
precludes the use of an aortic crossclamp.1 The use of
deep hypothermic circulatory arrest increases overall
safety; however, it is associated with an increased risk
of neurologic complications.3
We report a technique applied to 2 patients in which the
heart was kept warm and beating in normal sinus rhythm
while systemically cooling the body and organs. This strat-
egy attempts to eliminate the ventricular fibrillation associ-
ated with hypothermia, avoiding left ventricular distension
and endocardial ischemia, without clamping the aorta.METHODS
After systemic heparinization, we cannulated the right axillary artery
with an 8-mm Hemashield graft (Boston Scientific, Boston, Mass), con-
nected to a 3/83 3/8 straight connector (Sorin Group, Arvada, Colo). Ve-
nous cannulation consisted of a 21F 60-cm Biomedicus (Medtronic,
Minneapolis, Minn) femoral venous cannula placed percutanously into
the right femoral vein and a single-stage malleable cannula placed into
the superior vena cava (Medtronic). Cardiopulmonary bypass (CPB) was
initiated. To prevent distension, both patients had a vent placed in the right
superior pulmonary vein just after initiating CPB and before systemic cool-
ing began. A retrograde coronary sinus cannula, either the Gundryretrograde cannula (Medtronic) or the Edwards Life Science RC 2014 (Ed-
wards Life Science, Irvine, Calif) was placed into the coronary sinus di-
rectly with echocardiographic assistance. The Sorin BCD Vanguard
cardioplegia system (Sorin Group) was used to administer warm (37C)
pump blood at 300 mL/min into the coronary sinus. The retrograde circuit
pressures reached 175mmHg, and coronary sinus pressures of 30 to 40mm
Hg were maintained while the patients were being cooled.
Systemic cooling with a 10 to 12C gradient to 22 to 20C was initi-
ated with the Maquet Heater-Cooler Unit HCU 30 Dual Heater Cooler
(MAQUET Cardiovascular, Wayne, NJ).
Below arterial 32C, an effort was made to safely decrease the CPB flow
and thus the circuit line pressure, decreasing the incidence of competitive
cold antegrade blood from the CPB in-flow cannula.
When the patient venous line and nasopharyngeal temperatures equal-
ized at 22C to 20C, 30 mM of systemic potassium was administered
into the CPB pump to arrest the heart. The heart rate before potassium ad-
ministration was bradycardic (22–30 beats/min), normal sinus rhythm.
Cold blood cardioplegia was administered to arrest the heart for the rest
of the operation in an antegrade or retrograde route as per standard
techniques.RESULTS
Both patients underwent successful AVR and replace-
ment of the ascending aorta. The duration of sinus bradycar-
dia until cardiac arrest (ie, time of systemic cooling) was 60
and 65 minutes followed by potassium administration at
22.4C at 20.0C, respectively. There was no operativemor-
tality, and postoperatively, the patients showed no signs of
neurologic sequelae.DISCUSSION
This technique can be considered an alternative for pa-
tients in who aortic crossclamping is unsafe and might oth-
erwise be inoperable.
Constant coronary perfusion, particularly in patients with
hypertrophied ventricles,4 while maintaining sinus rhythm
and cardiac contractions is crucial for optimal myocardial
protection.5rdiovascular Surgery c Volume 144, Number 3 731
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61-7.Percutaneous device closure of a pseudoaneurysm arising from the
junction of the innominate artery and the aortaDawn C. Scantlebury, MBBS,a Oluseun O. Alli, MBBS,a Lyle D. Joyce, MD,b and Charanjit S. Rihal, MD,a
Rochester, MinnA percutaneous approach to management of thoracic aortic
disease has emerged as an alternative to open surgical repair
for carefully selected patients. Approaches that have been
used include stent-grafting and coil embolization.We report
a case of closure of a pseudoaneurysm of the junction of the
innominate artery and the aorta with an Amplatzer Vascular
Plug II (St Jude Medical, St Paul, Minn).CLINICAL SUMMARY
A46-year-oldwomanwas seen formanagement of a right
innominate artery pseudoaneurysm. Her surgical history in-
cluded extensive anterior mediastinal and sternal resection
in 2004 for recurrent Hodgkin lymphoma, and sternal recon-
struction with polytetrafluoroethylene (Gore-Tex; W. L.
Gore & Associates, Inc, Flagstaff, Ariz) and transposition
of the pectoralis majors. Seven years later after this opera-
tion, a painful pulsatile anterior chest wall mass developed.
This was found to be a moderate-to-large innominate artery
pseudoaneurysm that was closed percutaneously by deploy-
ment of a covered stent in the innominate artery. Some
months later, her symptoms recurred. Repeated imagingrevealed recurrence and enlargement of the pseudoaneur-
ysm, complete occlusion of the innominate artery near its or-
igin, and retrograde filling of the right carotid and subclavian
arteries from the left through the circle of Willis.
The patient was transferred to our institution for consid-
eration for operative repair. In light of her surgical history,
we believed that an attempt at open repair would be associ-
ated with significant risk. Review of the images revealed
that the pseudoaneurysm arose from the junction of the
aorta and the innominate artery (Figure 1, A), making it es-
sentially an aortic pseudoaneurysm. Its neck was suffi-
ciently narrow to attempt percutaneous repair with an
Amplatzer device.Technique
The procedure was performed in the cardiac catheteriza-
tion laboratory with the patient under conscious sedation
and local anesthesia. Access was obtained through a 6F
femoral arterial sheath. Aortic arch angiography, performed
with a 6F-pigtail catheter, demonstrated complete occlusion
of the innominate stent. A large pseudoaneurysm originated
from the junction of the aorta-innominate junction
(Figure 1, B).
Intravenous heparin was administered. The pigtail cathe-
ter was exchanged for an Amplatz left 1 catheter (Cook
Medical Inc, Bloomington, Ind), which, over a stiff, angled
guidewire, was carefully used to probe and cannulate the
pseudoaneurysmmouth, followed thereafter by selective in-
jection of the pseudoaneurysm (Figure 2, A). The pseudoa-
neurysm neck measured approximately 5 mm in diameter.
With a 0.038-inch extra-stiff Amplatz guidewire for sup-
port, a 6F Shuttle sheath (Cook Medical) was advancedery c September 2012
